The improved therapeutic effects of adefovir dipivoxil in patients with HBeAg-negative chronic hepatitis B offset against its increased cost compared to lamivudine

被引:1
|
作者
Buti, M.
Casado, M. A.
Calleja, J. L.
Salmeron, J.
Guilar, J. A.
Rueda, M.
Esteban, R.
机构
[1] Hosp Gen Valle Hebron, Dept Internal Med, Liver Unit, Barcelona, Spain
[2] Pharmacoecon & Outcomes Res, Madrid, Spain
[3] Hosp Puerto Hierro, Madrid, Spain
[4] Hosp Clin San Cecilio, Granada, Spain
[5] Hosp Virgen Del Rocio, Seville, Spain
[6] Gilead Sci Inc, Madrid, Spain
关键词
D O I
10.1016/S0168-8278(06)80485-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
485
引用
收藏
页码:S180 / S180
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 409 - 419
  • [2] Combination of adefovir dipivoxil with lamivudine vs. adefovir alone in lamivudine-resistant HBeAg-negative chronic hepatitis B patients
    Rapti, Irene N.
    Dimou, Evangelini
    Mitsoula, Panayota
    Hadziyannis, Stephanos J.
    [J]. HEPATOLOGY, 2006, 44 (04) : 558A - 559A
  • [3] Cost-effectiveness of two oral antiviral therapies, lamivudine and adefovir dipivoxil of HBeAg-negative chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : 172 - 172
  • [4] EFFECTIVENESS OF LONG-TERM COMBINATION THERAPY WITH ADEFOVIR DIPIVOXIL AND LAMIVUDINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B AND LAMIVUDINE RESISTANCE
    Manolakopoulos, Spilios
    Striki, Athanasia
    Papatheodoridis, George V.
    Deutsch, Melanie
    Mela, Maria
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    [J]. HEPATOLOGY, 2009, 50 (04) : 520A - 521A
  • [5] Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B
    Lampertico, P
    Vigano, M
    Manenti, E
    Lunghi, G
    Iavarone, M
    Del Ninno, E
    Colombo, M
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : 182 - 182
  • [6] Long term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Bhushan, B.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S95 - S95
  • [7] Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B
    Sung, Joseph J. Y.
    Lai, Jak-Yiu
    Zeuzem, Stefan
    Chow, Wan Chen
    Heathcote, E. Jenny
    Perrillo, Robert P.
    Brosgart, Carol. L.
    Woessner, Mary A.
    Scott, Susan A.
    Gray, D. Fraser
    Gardner, Stephen D.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (05) : 728 - 735
  • [8] Long-term treatment with adefovir dipivoxil is more cost-effective than lamivudine for HBeAg-negative patients with chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    [J]. HEPATOLOGY, 2005, 42 (04) : 354A - 354A
  • [9] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Tassopoulos, NC
    Heathcote, EJ
    Chang, TT
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Goodman, Z
    Ma, J
    Arterburn, S
    Xiong, S
    Currie, G
    Brosgart, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2673 - 2681
  • [10] Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B
    Lampertico, Pietro
    Marzano, Alfredo
    Levrero, Massimo
    Santantonio, Teresa
    Di Marco, Vito
    Brunetto, Maurizia
    Andreone, Pietro
    Sagnelli, Evangelista
    Fagiuoli, Stefano
    Mazzella, Giuseppe
    Raimondo, Giovanni
    Gaeta, Giovannibattista
    Ascione, Antonio
    [J]. HEPATOLOGY, 2006, 44 (04) : 693A - 694A